<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39352651</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8229</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Infectious diseases and therapy</Title><ISOAbbreviation>Infect Dis Ther</ISOAbbreviation></Journal><ArticleTitle>Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".</ArticleTitle><Pagination><StartPage>2469</StartPage><EndPage>2470</EndPage><MedlinePgn>2469-2470</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-024-01045-7</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiahua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinic Medicine, Jining Medical University, Jining, 272067, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinjie</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9328-0114</Identifier><AffiliationInfo><Affiliation>Department of Clinic Medicine, Jining Medical University, Jining, 272067, Shandong, People's Republic of China. wxj17854254607@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Dis Ther</MedlineTA><NlmUniqueID>101634499</NlmUniqueID><ISSNLinking>2193-6382</ISSNLinking></MedlineJournalInfo><CoiStatement>Jiahua Zhang and Xinjie Wang declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39352651</ArticleId><ArticleId IdType="pmc">PMC11499481</ArticleId><ArticleId IdType="doi">10.1007/s40121-024-01045-7</ArticleId><ArticleId IdType="pii">10.1007/s40121-024-01045-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Colaneri M, Genovese C, Fassio F, et al. Prognostic significance of NLR and PLR in COVID-19: a multi-cohort validation study. Infect Dis Ther. 2024;13:1147–57. 10.1007/s40121-024-00967-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11098972</ArticleId><ArticleId IdType="pubmed">38643431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671–92. 10.1016/j.cell.2021.02.029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–4. 10.1016/j.ajem.2020.11.058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7719281</ArticleId><ArticleId IdType="pubmed">33309506</ArticleId></ArticleIdList></Reference><Reference><Citation>Trofin F, Nastase E-V, Vâţă A, et al. The immune, inflammatory and hematological response in COVID-19 patients, according to the severity of the disease. Microorganisms. 2023;11:319. 10.3390/microorganisms11020319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9967162</ArticleId><ArticleId IdType="pubmed">36838284</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>